Form 4: Eli Lilly Director Acquires Shares Through Deferral Plan

Mary Lynne Hedley, a director at Eli Lilly, acquired 13 shares of common stock through a deferral plan, while also holding 98 shares indirectly through a trust.

Summary

• Mary Lynne Hedley, a director at Eli Lilly & Co, has reported a transaction involving the company's common stock.
• On March 18, 2024, Ms. Hedley acquired 13 shares of common stock at a price of $762.66 per share.
• These shares were acquired through the Lilly Directors' Deferral Plan, where they are deferred in lieu of cash compensation and will be settled after her separation from service.
• Ms. Hedley also indirectly holds 98 shares of common stock through a trust.
• She disclaims beneficial ownership of these trust-held securities except to the extent of her pecuniary interest.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction, which is generally neutral. The acquisition of shares by a director can be seen as a positive sign of confidence in the company.

Positives

• The acquisition of shares by a director may signal confidence in the company's future performance.
• The use of a deferral plan aligns the director's interests with the long-term success of the company.

Industry Context

This is a routine filing related to insider transactions, which is common for publicly traded companies like Eli Lilly. It reflects the compensation practices and ownership structure of the company's directors.

Comparison to Industry Standards

• Director stock acquisitions through deferral plans are a common practice among large publicly traded companies, including pharmaceutical companies like Eli Lilly.
• These plans are often used to align the interests of directors with the long-term performance of the company, similar to practices at companies like Pfizer and Merck.
• The reporting of these transactions via SEC Form 4 is a standard regulatory requirement for all publicly traded companies in the US.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it indicates director confidence in the company.
• The deferral plan aligns the director's interests with the long-term success of the company, which is beneficial for all stakeholders.

Key Dates

Keywords

Eli Lilly, Director, Stock Acquisition, Deferral Plan, Common Stock, Beneficial Ownership, SEC Form 4, Mary Lynne Hedley